US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRO Concept

1,717.39

-1.3967-0.08%

Number of Gainers:1

Number of Losers:1

Number of Flat:1

PE:- -

High:1,720.98

Open:1,717.09

Low:1,692.94

Close:1,718.79

Volume:2.52M

Turnover:487.48M

Market Cap:43.56B

Float Cap:41.71B

Loading ...

Will Analyst Optimism Around IQVIA (IQV) Signal Lasting Strength in Healthcare Data Leadership?

Simply Wall St.

Charles River Laboratories Forms Scientific Advisory Board to Advance New Approach Methodologies and Drive Industry Adoption of Alternative Testing Methods

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

THOMSON REUTERS

Charles River Laboratories International Inc. to Announce Third-Quarter 2025 Financial Results

Why Is Scholar Rock Stock Trading Lower On Monday?

Benzinga_recent_news

Robert W. Baird Remains a Hold on IQVIA Holdings (IQV)

Charles River Laboratories International Inc : Baird Raises Target Price to $178 From $161

THOMSON REUTERS

Lisata Therapeutics Signs License Agreement with Catalent

Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement

Charles River Laboratories and Toxys Announce Collaboration to Advance Non-Animal Developmental Toxicity Testing with ReproTracker

Charles River and Toxys Announce Collaboration to Validate the Use of Nams for Developmental Toxicity Testing

THOMSON REUTERS

BUZZ-Veeva climbs as TD Cowen upgrades to 'buy' and hikes PT to Street high

Charles River Labs Raised to Outperform From Market Perform by William Blair

Charles River upgraded to Outperform from Market Perform at William Blair

Charles River Labs Is Maintained at Outperform by Evercore ISI Group

Charles River Labs : Barclays Raises to Overweight From Equal-Weight

THOMSON REUTERS

Charles River Labs Shares Rise After Barclays Upgrade

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":1717.3889,"timestamp":1760731199999,"preClose":1718.7856,"halted":0,"volume":2524208,"delay":0,"changeRate":-0.000813,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-1.396729,"latestTime":"10-17 16:00:00 EDT","open":1717.092,"high":1720.9845,"low":1692.9362,"amount":487477018.62107,"amplitude":0.016319,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.773408,"peRate":37.25566,"turnoverRate":0.012015,"increases":1,"decrements":1,"flats":0,"marketCap":43559215104,"floatMarketCap":41707346944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":1720.9845,"amplitude":0.016319,"preClose":1718.7856,"low":1692.9362,"pbRate":"4.773408","latestPrice":1717.3889,"volume":2524208,"delay":0,"open":1717.092,"prevYearClose":1673.3123,"prevWeekClose":1652.5757,"prevMonthClose":1576.7454,"prevQuarterClose":1576.7454,"fiveDayClose":1652.5757,"twentyDayClose":1556.363,"sixtyDayClose":1689.7838,"secType":"PLATE","market":"US","turnoverRate":0.012015,"peRate":37.25566,"marketCap":43559215104,"floatMarketCap":41707346944,"timestamp":1760731199999,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":1,"down":1,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576778037","title":"Will Analyst Optimism Around IQVIA (IQV) Signal Lasting Strength in Healthcare Data Leadership?","url":"https://stock-news.laohu8.com/highlight/detail?id=2576778037","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576778037?lang=en_us&edition=fundamental","pubTime":"2025-10-17 01:24","pubTimestamp":1760635498,"startTime":"0","endTime":"0","summary":"IQVIA Holdings recently drew market attention ahead of its scheduled Q3 earnings report, with analysts expecting profitability to increase 2.7% year-over-year to US$2.68 per share and reaffirming strong confidence in the company's prospects in healthcare data and clinical research.\nAn interesting feature is IQVIA's record of surpassing bottom-line estimates in three of the past four quarters, supporting continued analyst optimism.\nWe'll explore how analyst confidence ahead of the earnings...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/137473239-main-header/1756256222159","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/137473239-main-header/1756256222159"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/will-analyst-optimism-around-iqvia-iqv-signal-lasting-streng","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/will-analyst-optimism-around-iqvia-iqv-signal-lasting-streng","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0882574055.USD","BK4585","LU1791710400.SGD","LU0477156797.USD","BK4121","LU1989764748.USD","LU0130518102.USD","HCSG","BK4530","LU0648001328.SGD","BK4137","LU1989764664.SGD","BK4551","LU0198837287.USD","LU1201861165.SGD","BK4588","LU1201861249.SGD","LU1261432733.SGD","AI","XBI","LU0130517989.USD","LU0130102774.USD","BK4543","IQV","LU0980610538.SGD","BK4528","XLV","LU0029874061.USD","BK4581","LU0128526141.USD","LABU","LU0130103400.USD","LU0477156953.USD","BK4023","LU0528227936.USD","BK4587","LU0648000940.SGD","LU1791710582.SGD"],"gpt_icon":0},{"id":"2575781738","title":"Charles River Laboratories Forms Scientific Advisory Board to Advance New Approach Methodologies and Drive Industry Adoption of Alternative Testing Methods","url":"https://stock-news.laohu8.com/highlight/detail?id=2575781738","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575781738?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:00","pubTimestamp":1760529630,"startTime":"0","endTime":"0","summary":"Charles River Laboratories Forms Scientific Advisory Board to Advance New Approach Methodologies and Drive Industry Adoption of Alternative Testing Methods. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire  on October 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nNDLYWzvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","CRL","LU1815336091.USD","BK4585","BK4530","BK4588","LU0757428866.USD","BK4121"],"gpt_icon":0},{"id":"2575431781","title":"Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2575431781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575431781?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:00","pubTimestamp":1760529602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUA9SYHHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0390134368.USD","CRL","BK4588","LU1815336091.USD","BK4121","LU0757428866.USD","BK4530"],"gpt_icon":0},{"id":"2575297472","title":"Charles River Laboratories International Inc. to Announce Third-Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2575297472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575297472?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:00","pubTimestamp":1760443228,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International Inc. will release its third-quarter 2025 financial results on Wednesday, November 5th, before the market opens. A conference call to discuss the results is scheduled for Wednesday, November 5th, at 9:00 a.m. ET. Investors can listen to a live webcast or access a replay through the Investor Relations section of the Company's website at ir.criver.com.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire  on October 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL6zhCDM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4530","LU0757428866.USD","LU0390134368.USD","CRL","BK4121","BK4588","LU1815336091.USD"],"gpt_icon":0},{"id":"2575819832","title":"Why Is Scholar Rock Stock Trading Lower On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2575819832","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575819832?lang=en_us&edition=fundamental","pubTime":"2025-10-14 01:52","pubTimestamp":1760377920,"startTime":"0","endTime":"0","summary":"Scholar Rock stock falls as FDA issues Form 483 to Catalent; company to meet FDA, while apitegromab shows lean mass preservation in trial.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/13/Scholar-Rock.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/13/Scholar-Rock.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/25/10/48183276/why-is-scholar-rock-stock-trading-lower-on-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/10/48183276/why-is-scholar-rock-stock-trading-lower-on-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","SMA","BK4532","BK4121","BK4007","BK4530","LU1815336091.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU0757428866.USD","LU0390134368.USD","BK4599","CRL","LU1093756168.USD","SRRK","BK4588","BK4217","BK4139"],"gpt_icon":1},{"id":"2575286445","title":"Robert W. Baird Remains a Hold on IQVIA Holdings (IQV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2575286445","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575286445?lang=en_us&edition=fundamental","pubTime":"2025-10-14 00:55","pubTimestamp":1760374534,"startTime":"0","endTime":"0","summary":"In a report released today, Eric Coldwell from Robert W. Baird maintained a Hold rating on IQVIA Holdings, with a price target of $224.00. The comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/robert-w-baird-remains-a-hold-on-iqvia-holdings-iqv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/robert-w-baird-remains-a-hold-on-iqvia-holdings-iqv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4094","LU0882574055.USD","LU0648001328.SGD","LU0198837287.USD","BK4588","IQV","LU1261432733.SGD","LU0648000940.SGD","LU1989764664.SGD","BK4585","XELB","LU0130102774.USD","LU0130103400.USD","LU0528227936.USD","LU1201861249.SGD","LU0130518102.USD","LU0477156797.USD","LU0980610538.SGD","LU0130517989.USD","LU1989764748.USD","BK4530","LU0477156953.USD","LU1791710582.SGD","LU1791710400.SGD","LU1201861165.SGD"],"gpt_icon":0},{"id":"2575942103","title":"Charles River Laboratories International Inc : Baird Raises Target Price to $178 From $161","url":"https://stock-news.laohu8.com/highlight/detail?id=2575942103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575942103?lang=en_us&edition=fundamental","pubTime":"2025-10-13 13:50","pubTimestamp":1760334633,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nFWN3VU0RK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0757428866.USD","BK4585","LU1815336091.USD","LU0390134368.USD","CRL","BK4530","BK4588","BK4121"],"gpt_icon":0},{"id":"2574974528","title":"Lisata Therapeutics Signs License Agreement with Catalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2574974528","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574974528?lang=en_us&edition=fundamental","pubTime":"2025-10-09 03:27","pubTimestamp":1759951648,"startTime":"0","endTime":"0","summary":"An announcement from Lisata Therapeutics ( ($LSTA) ) is now available. On October 8, 2025, Lisata Therapeutics entered into a non-exclusive license...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lisata-therapeutics-signs-license-agreement-with-catalent?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lisata-therapeutics-signs-license-agreement-with-catalent?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4585","CTLT","BK4139","BK4007","BK4530","BK4588","BK4539"],"gpt_icon":0},{"id":"2573492301","title":"Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2573492301","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573492301?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:30","pubTimestamp":1759926600,"startTime":"0","endTime":"0","summary":"Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag payloads across multiple ADCs designed to address difficult-to-treat diseases  Catalent’s preclinical study resu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/08/3163348/18623/en/Lisata-Therapeutics-and-Catalent-Announce-Global-Antibody-Drug-Conjugate-ADC-License-Agreement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4231","BK4585","BK4139","BK4530","BK4007","CDMO","BK4588","BK4539","CTLT","BK4080","ADC"],"gpt_icon":0},{"id":"2573928116","title":"Charles River Laboratories and Toxys Announce Collaboration to Advance Non-Animal Developmental Toxicity Testing with ReproTracker","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928116","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928116?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:00","pubTimestamp":1759924837,"startTime":"0","endTime":"0","summary":"Charles River Laboratories and Toxys Announce Collaboration to Advance Non-Animal Developmental Toxicity Testing with ReproTracker. Charles River Laboratories International Inc. has announced a collaboration with Toxys to enhance developmental and reproductive toxicology  testing using New Approach Methodologies . Through this partnership, Charles River's clients will gain access to ReproTracker, a human stem cell-based in vitro assay that identifies developmental toxicity hazards of new drugs and chemicals. The collaboration aims to accelerate the adoption and validation of ReproTracker as a non-animal alternative to traditional in vivo approaches, supporting the 3Rs principles of Replacement, Reduction, and Refinement in toxicology testing while maintaining high safety standards for patients and consumers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gene","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL8zDvKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0390134368.USD","CRL","BK4585","LU0757428866.USD","LU1815336091.USD","BK4121","BK4530"],"gpt_icon":0},{"id":"2573928677","title":"Charles River and Toxys Announce Collaboration to Validate the Use of Nams for Developmental Toxicity Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928677","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928677?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:00","pubTimestamp":1759924801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUA2QRM32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4530","LU0390134368.USD","BK4588","LU1815336091.USD","BK4121","LU0757428866.USD","CRL","BK4585"],"gpt_icon":0},{"id":"2573957638","title":"BUZZ-Veeva climbs as TD Cowen upgrades to 'buy' and hikes PT to Street high","url":"https://stock-news.laohu8.com/highlight/detail?id=2573957638","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573957638?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:19","pubTimestamp":1759839564,"startTime":"0","endTime":"0","summary":"BUZZ-Veeva climbs as TD Cowen upgrades to 'buy' and hikes PT to Street high** Shares of healthcare tech firm Veeva Systems VEEV.N rise 1.8% to $305 premarket** Brokerage TD Cowen raises stock rating to \"buy\" from \"hold\"; raises PT to Street high of $380 from $297** New PT represents a 26.8% premium to stock's last close** Veeva’s new platform, Vault CRM, is gaining momentum, with 9 of the top 20 pharma companies already signed on, far ahead of Salesforce CRM.N, brokerage says** Brokerage says partnership with IQVIA IQV.N is seen as a major positive, adding it removes \"lingering overhang and expanding new opportunities\" especially in clinical trial software** VEEV is \"becoming/if not already the dominant player\" in R&D software space, mirroring its established leadership in pharma commercial software - brokerage** TD Cowen says shift towards insourcing and functional service providers represent a \"secular tailwind for VEEV\"** As of last close, stock up 42% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nL3N3VO0OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","IE00BQXX3C00.GBP","LU0820562030.AUD","LU0251131958.USD","LU0234570918.USD","LU2357305700.SGD","LU1551013425.SGD","BK4561","LU0082616367.USD","LU1201861249.SGD","LU0889565833.HKD","VEEV","LU1201861165.SGD","LU1366333091.USD","LU1989764664.SGD","LU0170899867.USD","LU0648000940.SGD","LU0266013472.USD","LU1064131342.USD","BK4505","LU0211328371.USD","LU0557290698.USD","BK4581","BK4579","LU0354030511.USD","LU1046421795.USD","LU2461242641.AUD","IQV","LU0234572021.USD","LU1496350171.SGD","BK4167","LU0980610538.SGD","LU0472753341.HKD","LU2236285917.USD","LU2361045086.USD","LU0289739343.SGD","LU1923623000.USD","LU0187121727.USD","LU2265009873.SGD","LU1496350502.SGD","LU1988902786.USD","LU0109392836.USD","LU1823568750.SGD","BK4567","LU1804176565.USD","BK4543","LU0198837287.USD","BK4530","LU0719512351.SGD"],"gpt_icon":1},{"id":"2573606783","title":"Charles River Labs Raised to Outperform From Market Perform by William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2573606783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573606783?lang=en_us&edition=fundamental","pubTime":"2025-10-06 23:37","pubTimestamp":1759765020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 06, 2025 11:37 ET (15:37 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU1815336091.USD","CRL","LU0757428866.USD","BK4588","BK4585","BK4530","LU0390134368.USD"],"gpt_icon":0},{"id":"2573679941","title":"Charles River upgraded to Outperform from Market Perform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679941?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748431,"startTime":"0","endTime":"0","summary":"William Blair upgraded Charles River (CRL) to Outperform from Market Perform without a price target The firm believes news updates in recent weeks ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/charles-river-upgraded-to-outperform-from-market-perform-at-william-blair-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/charles-river-upgraded-to-outperform-from-market-perform-at-william-blair-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0757428866.USD","LU1815336091.USD","CRL","LU0390134368.USD","BK4588","BK4530","BK4121"],"gpt_icon":0},{"id":"2572168138","title":"Charles River Labs Is Maintained at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2572168138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572168138?lang=en_us&edition=fundamental","pubTime":"2025-10-04 00:08","pubTimestamp":1759507680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 03, 2025 12:08 ET (16:08 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CRL","LU0390134368.USD","LU1815336091.USD","BK4121","LU0757428866.USD","BK4585","BK4530"],"gpt_icon":0},{"id":"2572836509","title":"Charles River Labs : Barclays Raises to Overweight From Equal-Weight","url":"https://stock-news.laohu8.com/highlight/detail?id=2572836509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572836509?lang=en_us&edition=fundamental","pubTime":"2025-10-03 18:22","pubTimestamp":1759486927,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nAZN4LSR79:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0757428866.USD","BK4585","BK4530","BK4121","LU1815336091.USD","LU0390134368.USD","BK4588","CRL"],"gpt_icon":0},{"id":"2572596547","title":"Charles River Labs Shares Rise After Barclays Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2572596547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572596547?lang=en_us&edition=fundamental","pubTime":"2025-10-03 02:58","pubTimestamp":1759431497,"startTime":"0","endTime":"0","summary":"Charles River Laboratories (CRL) stock rose 3.6% in recent trading on Thursday after Barclays upgraded the stock to overweight from equal weight.Intraday trading volume stood at over 987,000 shares compared with a daily average of roughly 891,000.Price: 176.69, Change: +6.21, Percent Change: +3.64","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0390134368.USD","BK4121","LU0757428866.USD","BK4530","LU1815336091.USD","BK4588","CRL.AU","CRL","BK7095"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}